Lisa Kerber

Senior Vice President, Global Real World Evidence Strategy

Lisa is responsible for setting the strategic direction for the Lumanity RWE business globally. This includes offering, client engagement, commercial and M&A strategy in the US and Europe.

Lisa spent over 20 years with IMS Health, in multiple client-facing roles, including consulting, business development, account management, and general management. In her last role with IMS, Lisa led the US RWE and Commercial Effectiveness services business, where she oversaw all US offerings centered on patient-level data (RWD), including commercial, medical (HEOR, safety) and clinical use cases, and encompassing open and closed claims, longitudinal prescription, and EHR data assets.

Before joining Lumanity, Lisa was Chief Operating Officer at Prognos, a healthcare startup focused on creating value from the integration of diagnostic results data with legacy RWD to create new patient-finding offerings.

Lisa holds a Bachelor of Arts degree in English from Temple University in Philadelphia, Pennsylvania.